Proffitt & Goodson’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,524
| Closed | -$175K | – | 272 |
|
|
2025
Q1 | $175K | Buy |
2,524
+280
| +12% | +$19.4K | 0.03% | 110 |
|
|
2024
Q4 | $193K | Buy |
2,244
+39
| +2% | +$3.36K | 0.03% | 106 |
|
|
2024
Q3 | $263K | Buy |
2,205
+49
| +2% | +$5.83K | 0.04% | 103 |
|
|
2024
Q2 | $308K | Buy |
2,156
+10
| +0.5% | +$1.43K | 0.05% | 95 |
|
|
2024
Q1 | $276K | Buy |
2,146
+2,046
| +2,046% | +$263K | 0.05% | 98 |
|
|
2023
Q4 | $10.3K | Buy |
+100
| New | +$10.3K | ﹤0.01% | 184 |
|